It is also noteworthy that some, but not all, aCL antibodies from APS patients have been observed to activate TLR’s [18], highlighting the heterogeneity of these antibodies with respect to specificity in their interaction with β2GPI. The gene discussed is ACLY; the disease is autoimmune polyendocrinopathy.